Document is current

Article History

Received: 17 April 2025

Accepted: 30 September 2025

First Online: 1 March 2026

Declarations

:

: Brooke M. Currie and Georges Van Kriekinge are employed by and hold financial equities in GSK. Aurélie Pimienta was employed by GSK at the time of the conduct of this study. Cory Saucier, and KD Jacobs are employed by QualityMetric, which received funding from GSK for the study. Laura Tesler Waldman was employed by QualityMetric at the time of the study. Christine M. Salvatore reports having received consulting fees from GSK. These authors declare no other financial and non-financial relationships and activities.

: The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Institutional Review Board (IRB) of WCG (IRB tracking number 20226194, sponsor protocol code 218971, board action date 11/22/2022). The study complied with all applicable laws regarding participant privacy.

: All participants electronically signed and returned informed consent forms prior to participating in an interview. Transcripts were de-identified, and all study participants’ records were archived in a manner consistent with HIPAA regulations.

: No individual data were presented in this study, and consent for publication was therefore not required.

: Data sharing statement.

: All data used for this publication was received by GSK. For access to anonymized subject level data, please contact GSK. Additional information on the study materials can be provided on request.